{
    "doi": "https://doi.org/10.1182/blood.V128.22.4161.4161",
    "article_title": "Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma ",
    "article_date": "December 2, 2016",
    "session_type": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster III",
    "abstract_text": "From November 2012 to July 2014, brentuximab vedotin (BV) was available in Italy for patients with relapsed Hodgkin's lymphoma (HL) outside a clinical trial context based on a local disposition of the Italian Drug Agency (AIFA) issued according to a national law (Law 648/96: \"medicinal products that are provided free of charge on the national health service\"). A large Italian observational retrospective study was conducted on the use of BV in the everyday clinical practice to check if clinical trial results are confirmed even in a real life context. Primary endpoint was the best response; secondary endpoints were the overall response rate at the end of the treatment, duration of response, survival and the safety profile. BV was infused intravenously at the dose of 1.8 mg/kg every 3 weeks. A total of 234 HL patients were treated in 40. All patients had histologically documented CD30+ HL; 49% had relapsed and 51% had refractory disease. Patients were heavily pretreated with a median of 3 previous therapies (including autologous stem cell transplant [SCT] in the 69% of cases). Best response was observed after a median of 4 cycles in 140 patients (59.8%): 74 (31.6%) patients obtained a complete response (CR) and 66 (28.2%) achieved a partial response (PR); overall response rate at the end of the treatment was 48.3% (62 CR and 51 PR). The best response rate was higher in the elderly subset (>60 years): 14 (50%) CR and 5 (17.8%) PR. Disease free survival was 26.3% at 29 months and progression free survival 31.9% at 55 months. We identified 30 long term responders (patients with a response \u2265 12 months) of whom 18 are still in CR, 7 with a consolidative SCT and 11 without any consolidative procedure. Duration of response did not differ who achieved at least PR and then either did or did not undergo consolidative SCT. All patients were included in the safety profile for the analysis; in general, the treatment was well tolerated in everyday clinical practice and the toxicity profile was closely similar to the previously published data; no death has been linked to BV-induced toxicity. This preliminary analysis could indicate that BV displays a number of features favoring its use as a bridge to transplant in patients with active disease who achieve a suboptimal response to salvage treatment. Even in a real life context, BV induces clinical responses quite rapidly, i.e. within the first 4 cycles in most responders, thus permitting the timely application of the transplantation phase. BV displays a favorable toxicity profile, without overlapping toxicities with most of the agents employed in high-dose conditioning regimens. Furthermore, for HL patients ineligible for transplant or for who transplant failed, may represent a feasible effective therapeutic option. Disclosures Rusconi: Janssen: Consultancy, Other: Congress attendance; Teva: Consultancy, Other: Congress attendance; Takeda: Consultancy. Spina: Teva Pharmaceuticals Industries: Membership on an entity's Board of Directors or advisory committees, Other: Speaker Fee; Mundipharma: Membership on an entity's Board of Directors or advisory committees, Other: Speaker Fee. Zinzani: Abbvie: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; MorphoSys: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees; Celegene: Membership on an entity's Board of Directors or advisory committees; Roche: Membership on an entity's Board of Directors or advisory committees.",
    "topics": [
        "brentuximab vedotin",
        "hodgkin's disease",
        "observational studies",
        "toxic effect",
        "transplantation",
        "autologous stem cell transplant",
        "complete remission",
        "duration of treatment",
        "hodgkin's disease, recurrent",
        "partial response"
    ],
    "author_names": [
        "Alessandro Broccoli, MD",
        "Alessandro Pulsoni, MD",
        "Luigi Rigacci",
        "Caterina Patti, MD",
        "Guido Gini, MD",
        "Donato Mannina, MD",
        "Monica Tani",
        "Chiara Rusconi, MD",
        "Alessandra Romano, MD PhD",
        "Anna Vanazzi",
        "Barbara Botto",
        "Armando Santoro",
        "Stefan Hohaus",
        "Gian Matteo Rigolin",
        "Pellegrino Musto",
        "Patrizio Mazza, MD",
        "Stefano Molica, MD",
        "Paolo Corradini",
        "Angelo Fama, MD",
        "Francesco Gaudio",
        "Michele Merli",
        "Fioravante Ronconi",
        "Giuseppe Gritti, MD",
        "Daniele Vallisa, MD",
        "Patrizia Tosi",
        "Anna Marina Liberati, MD",
        "Antonello Pinto",
        "Vincenzo Pavone, MD",
        "Filippo Gherlinzoni, MD",
        "Elena Cavalieri, MD",
        "Stefano Volpetti",
        "Andrea Visentin, MD",
        "Maria Cecilia Goldaniga, MD",
        "Maurizio Bonfichi",
        "Amalia De Renzo",
        "Corrado Schiavotto",
        "Michele Spina",
        "Angelo Michele Carella",
        "Lisa Argnani",
        "Pier Luigi Zinzani, MD PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Alessandro Broccoli, MD",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Pulsoni, MD",
            "author_affiliations": [
                "Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luigi Rigacci",
            "author_affiliations": [
                "Hematology Department, University and Hospital Careggi, Firenze, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Patti, MD",
            "author_affiliations": [
                "Dept. of Hematology, Azienda Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Gini, MD",
            "author_affiliations": [
                "Affiliate Clinic of Hematology- Ospedali Riuniti, Ancona, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Donato Mannina, MD",
            "author_affiliations": [
                "Hematology Unit, Ospedale Papardo, Messina, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Tani",
            "author_affiliations": [
                "Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Rusconi, MD",
            "author_affiliations": [
                "Division of Hematology, Niguarda Hospital, Milan, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Romano, MD PhD",
            "author_affiliations": [
                "Division of Haematology, AOU, Catania, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Vanazzi",
            "author_affiliations": [
                "Division of Clinical Haemato-Oncology, European Institute of Oncology, Milano, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Botto",
            "author_affiliations": [
                "SC Ematologia, Azienda Ospedaliera Universitaria Citt\u00e0 della Salute e della Scienza, Torino, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Armando Santoro",
            "author_affiliations": [
                "Humanitas University and Humanitas Research Hospital, Milano, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefan Hohaus",
            "author_affiliations": [
                "Institute of Hematology, Catholic University, Rome, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gian Matteo Rigolin",
            "author_affiliations": [
                "Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Ferrara, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pellegrino Musto",
            "author_affiliations": [
                "IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizio Mazza, MD",
            "author_affiliations": [
                "C/O Ospedale Moscati Dept. of Hematology-Oncology, Taranto, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Molica, MD",
            "author_affiliations": [
                "Department of Hematology, Ciaccio-Pugliese Hospital, Catanzaro, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Corradini",
            "author_affiliations": [
                "Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelo Fama, MD",
            "author_affiliations": [
                "Hematology Unit, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Gaudio",
            "author_affiliations": [
                "Hematology Unit, Policlinico di Bari, Bari, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Merli",
            "author_affiliations": [
                "Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fioravante Ronconi",
            "author_affiliations": [
                "Division of Hematology, Cardarelli Hospital, Napoli, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Gritti, MD",
            "author_affiliations": [
                "Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniele Vallisa, MD",
            "author_affiliations": [
                "Hematology Unit, G. da Saliceto Hospital, Piacenza, Italy "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizia Tosi",
            "author_affiliations": [
                "Hematology Unit, Infermi Hospital Rimini, Rimini, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Marina Liberati, MD",
            "author_affiliations": [
                "Hematology, Ospedale Perugia, Perugia, Italy "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonello Pinto",
            "author_affiliations": [
                "Hematology-Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione Pascale, IRCCS, Napoli, Italy "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincenzo Pavone, MD",
            "author_affiliations": [
                "Division of Hematology, Ospedale G. Panico, Tricase, Lecce, Italy "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Filippo Gherlinzoni, MD",
            "author_affiliations": [
                "Hematology Unit, Ca' Foncello Hospital, Treviso, Italy "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elena Cavalieri, MD",
            "author_affiliations": [
                "Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Volpetti",
            "author_affiliations": [
                "Department of Hematology, DISM, Azienda Sanitaria Universitaria Integrata, Udine, Italy "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Visentin, MD",
            "author_affiliations": [
                "Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Cecilia Goldaniga, MD",
            "author_affiliations": [
                "OncoHematology Unit, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maurizio Bonfichi",
            "author_affiliations": [
                "Hematology, IRCCS Policlinico San Matteo, Pavia, Italy "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Amalia De Renzo",
            "author_affiliations": [
                "Hematology, AOU Federico II Napoli, Napoli, Italy "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Corrado Schiavotto",
            "author_affiliations": [
                "Hematology, San Bortolo Hospital, Vicenza, Italy "
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Spina",
            "author_affiliations": [
                "Division of Medical Oncology A, National Cancer Institute, Aviano, Italy "
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelo Michele Carella",
            "author_affiliations": [
                "Division of Hematology 1, IRCCS A.O.U. San Martino IST, Genova, Genova, Italy"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lisa Argnani",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pier Luigi Zinzani, MD PhD",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 40,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-06T02:28:42",
    "is_scraped": "1"
}